Comparison of intrathecal buprenorphine and morphine as adjuvant to hyperbaric Ropivacaine 0.75% in patients undergoing urological procedures.

Comparison of intrathecal buprenorphine and morphine as adjuvant to hyperbaric Ropivacaine 0.75% in patients undergoing urological procedures under spinal anaesthesia .A prospective randomized double blind study. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056643

Enrollment

100

Registered

2023-08-18

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: INJECTION BUPRENORPHINE: The study adjuvant buprenorphine 60mcg is added to fixed dose of 2.8ml of hyperbaric Ropivacaine 0.75% intrathecally in patients undergoing elective urological

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASA I and ASA II BMI <40

Exclusion criteria

Exclusion criteria: 1.Patients allergic to drugs used in study 2.Duration of surgery more than 120 minutes 3.Having contraindications to spinal anesthesia.

Design outcomes

Primary

Measure	Time frame
We aim to find the better additive among intrathecal buprenorphine 60mcg & morphine 150mcg & as an adjuvant to Ropivacaine in terms of the mean duration of postoperative analgesia,hemodynamic variations & adverse effects.Timepoint: Baseline	—

Secondary

Measure	Time frame
1)post operative pain score 2)Total analgesic drug consumption in 24hrs. 3)Adverse effectsTimepoint: 10min 30mins 1st hour 2nd h 4th hour 8th hour 16th hour & 24th hour.	—

Countries

India

Contacts

Public ContactDr CHINNAM PRAVEEN KUMAR

SDM COLLEGE OG MEDICAL SCIENCE AND HOSPITAL

drimransholapur@gmail.com9731047204

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026